Guiding consumers since 2009

Investment guide: The private healthcare sector

By Jessica Anne Wood

The private healthcare sector in South Africa is comprised of three main players: Medi-Clinic International, Netcare Limited and Life Healthcare. According to Stefan du Toit, PSG Wealth Durbanville Stockbroking, Medi-Clinic is the largest of the three with a market capitalisation of R153 billion, followed by Netcare with R54 billion and Life Healthcare with R40 billion.

All three of these hospital groups are listed on the Johannesburg Stock Exchange (JSE). This guide looks at investing in the private healthcare industry, and how the three big healthcare groups compare.

Investing in the private healthcare industry

Despite the weakening of the economy, du Toit noted: “The demand for private healthcare is expected to remain resilient due to the defensive nature of the business and the state of the public health care system in South Africa.”

“Investment in the private healthcare industry has historically been viewed as lower risk due to high barriers of entry to new participants in these markets and the defensive nature of the business. However, with that in mind it is important to realise that it is a highly regulated industry and due to the uncertain nature of regulations in South Africa, companies have in the past diversified their income streams to include more offshore earnings.”

The defensive nature of these companies, as well as the good cash generation, have historically made private healthcare a good investment on the JSE. As a result, these companies “tend to trade at premium valuation multiples to the general market,” explained du Toit.

Currently, Netcare and Life Healthcare are trading at historic price-to-earnings multiples of 21 times.. “Life Healthcare currently pays out a bigger portion of free cash flow to shareholders with a dividend yield of 4.05% compared to the lower yield of 2.51% on Netcare. Both Netcare and Life Healthcare have experienced severe price pressure over the last 12 months as a result of regulatory uncertainty and competition commission inquiries, with Netcare shedding approximately 16% and Life Healthcare down seven percent,” added du Toit.

The impact of the NHI on the private healthcare sector

The government has plans to implement a National Health Insurance (NHI), which is a government-funded system allowing free medical access to citizens. According to du Toit, this proposal “may lead companies to reconsider its current investment options. The NHI is currently in its proposal phase.  Whether an already overburdened public sector can afford this is another question, but the proposal of greater access to free medical services and resultant price reductions will in all likelihood have a negative impact on profitability and margins in the long run.”

Du Toit added: “We believe the private healthcare industry is a quality industry with good historic margins, cash generation and return on equity. Most of these companies have quality management, which are not negotiable. Over the long run the management teams and companies tend to reward investors with decent returns and wealth creation.”

Life Healthcare fined

The healthcare industry faces a number of obstacles at times due to the strict regulatory environment in which they operate. For example, due to failure to notify the Competition Commission of a planned merger between Life Healthcare and Joint Medical Holdings (JMH), both groups have agreed to pay a fine of R10 million.

In a document released by the Competition Tribunal, it revealed that the Commission received a complaint from the National Hospital Network regarding a merger between Life Healthcare and JMH. The complaint stated that the merger was a violation of the Competition Act, as consent from the Competition Commission had not been received prior to the merger taking place.

Du Toit clarified: “Parties to large mergers are required to disclose the nature of such transactions to the competition authorities to assess if it is in the best interest of the general public.”

Following this, Life Healthcare (LHG) agreed that it would disinvest from JMH. The Tribunal explained: “The Respondents have agreed that LHG would disinvest from JMH and that JMH would acquire nearly all of LHG's shareholding by way of a share buy-back arrangement and that some existing doctor shareholders would acquire the balance of LHG's shareholding. This transaction would result in the termination of the current shareholders agreement between JMH and its shareholders. This transaction it is believed, did not result in one or more firms acquiring or establishing control of JMH and would therefore not constitute a merger. The transaction was completed on 26 February 2014 and as such the co-operation between LHG and JMH which concerned the Commission also ceased.”

André Meyer, CEO of the Life Healthcare Group, said: “Life Healthcare Group acknowledges that the Competition Tribunal has confirmed the consent agreement between ourselves, the Competition Commission and Joint Medical Holdings.

“Life Healthcare Group is committed to complying with the terms of the consent agreement which includes payment of a fine, within three months of the date of the confirmation.”

The severity of the fine levelled against Life Healthcare, according to du Toit, “shows how serious the competition commissions will take any contraventions.”

Du Toit concluded: “Investors that do not have exposure to the private healthcare industry, should definitely consider adding the industry to their portfolios by investing in these quality companies on the JSE.”

Recent Articles

Featured What’s the deal with underwriting?

When you apply for a long-term insurance policy, a financial adviser will ask some personal questions about your lifestyle, family history, health, and even ask you to take some medical tests. This process is called underwriting, but is it really necessary?

 

How are you taxed on your retrenchment package?

Unemployment is one of the biggest problems in South Africa. The emergence of the Covid-19 pandemic has exacerbated the situation with a lot of companies retrenching their employees.  When retrenched, you’ll receive a retrenchment package, but do you know how much tax you’re liable for?

Car repossessed – don’t be taken for a ride

When the country is facing an economic downturn, chances are your finances will feel the pinch. This can lead you to make bad financial decisions such as skipping your vehicle payments. But every decision has consequences and if you don’t pay your instalment, the bank will repossess your car. But what can you do when this happens?

 

Why you should consider gap cover

Your medical aid should protect you from incurring large medical bills when you’re sick. But what if your plan doesn’t cover the full cost of your medical expenses? We got in touch with insurance experts to find out whether gap cover is worth having.

Deals

Office furniture at discounted prices at BDK

Price: Available on request
When: Daily
Where: Johannesburg

Da Vincis Happy Hour Special

Price: Available on request
When: Daily
Where: Cape Town

Use your Absa card and get 30% cashback at Dis-chem

Price: Available on request
When: Daily
Where: Nationwide


Latest Guide

Guide to debt rehabilitation solutions